Anika Therapeutics reported $623M in Market Capitalization for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbott ABT:US $ 205.99B 6.31B
Acceleron Pharma XLRN:US $ 7.62B 606.02M
Acorda Therapeutics ACOR:US $ 45.26M 955.08K
Adamas Pharmaceuticals ADMS:US 239.75M 41.19M
Agenus AGEN:US $ 1.22B 664.46M
Agios Pharmaceuticals AGIO:US $ 3.39B 211.72M
Anika Therapeutics ANIK:US $ 623M 38.49M
Arrowhead Research ARWR:US $ 8.62B 1.74B
Chemocentryx CCXI:US $ 933.95M 2.64B
Clovis Oncology CLVS:US $ 606.48M 127.32M
Dicerna Pharmaceuticals DRNA:US $ 2.87B 918.39M
Enanta Pharmaceuticals ENTA:US $ 888.79M 106.09M
Flexion Therapeutics FLXN:US $ 411.02M 35.8M
Halozyme Therapeutics HALO:US $ 6.47B 491.5M
Heron Therapeutics HRTX:US $ 1.58B 98.85M
Immunogen IMGN:US $ 1.32B 300.21M
Insmed INSM:US $ 3.22B 293.47M
Integra Lifesciences IART:US $ 5.77B 69.01M
Intrexon XON:US $ 1.35B 76.37M
Johnson & Johnson JNJ:US $ 433825.66M 1140.33M
Karyopharm Therapeutics KPTI:US $ 774.96M 14.69M
Ligand Pharmaceuticals LGND:US $ 2.18B 347.98M
Macrogenics MGNX:US $ 1.62B 176.65M
Merit Medical Systems MMSI:US $ 3.62B 286.03M
Peregrine Pharmaceuticals PPHM:US $ 1.57B 458.25M
Rigel Pharmaceuticals RIGL:US $ 738.51M 156.7M
Sangamo Biosciences SGMO:US $ 1.72B 78.47M
Sanofi SAN:FP 111.4B 5.33B
Stryker SYK:US $ 97.85B 6.08B
Surmodics SRDX:US $ 752.34M 18.94M
Veracyte VCYT:US $ 2.69B 912.75M
Xencor XNCR:US $ 2.01B 489.02M
Zimmer Biomet Holdings Inc ZBH:US $ 33.53B 180.77M